Salmonellosis

disease
On this page

Also known as infections, Salmonellarare form of salmonellosisSalmonella infection

Summary

Salmonellosis (MONDO:0000827) is a disease (an umbrella term covering 5 Mondo subtypes) and 10 clinical trials. Top therapeutic interventions include sodium chloride, ampicillin sodium, and ceftriaxone sodium. A subtype of primary bacterial infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: 1-9 / 100 000 (Europe)
  • Umbrella term: 5 Mondo subtypes
  • Clinical trials: 10

Clinical features

Epidemiology

Prevalence records

1 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Point prevalence1-9 / 100 000EuropeNot yet validated

Identifiers

Disease identifiers

FieldValue
Canonical namesalmonellosis
Mondo IDMONDO:0000827
MeSHD012480
Orphanet795
DOIDDOID:0060859
NCITC157974
SNOMED CT302231008
UMLSC0036117
MedGen48542
MedDRA10039447
Is cancer (heuristic)no

Also known as: infections, Salmonella · rare form of salmonellosis · Salmonella infection

Disease family

This is a subtype of primary bacterial infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious diseasebacterial infectious diseaseprimary bacterial infectious diseasesalmonellosis

Related subtypes (36): Buruli ulcer disease, sennetsu fever, pinta disease, chancroid, gonorrhea, anthrax infection, leprosy, botulism, diphtheria, tetanus, bartonellosis, brucellosis, campylobacteriosis, glanders, granuloma inguinale, legionellosis, leptospirosis, listeriosis, Mycobacterium avium complex disease, ornithosis, rhinoscleroma, staphyloenterotoxemia, syphilis, cholera, ehrlichiosis, melioidosis, tuberculosis, tularemia, plague, Q fever, shigellosis, Lyme disease, relapsing fever, spirillary rat-bite fever, streptobacillary rat-bite fever, Borrelia miyamotoi disease

Subtypes (5): typhoid fever, Salmonella gastroenteritis, invasive non-typhoidal salmonellosis, paratyphoid fever, salmonella discitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 10.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified6
PHASE22
PHASE31
PHASE1/PHASE21

Top trials by phase / activity

NCTPhaseStatusTitle
NCT01608815PHASE3COMPLETEDStudy of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects
NCT06213506PHASE2ACTIVE_NOT_RECRUITINGA Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants
NCT07286370PHASE2RECRUITINGA Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants
NCT05480800PHASE1/PHASE2COMPLETEDA Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever
NCT04694235Not specifiedACTIVE_NOT_RECRUITINGEgg Intervention During Pregnancy in Indonesia
NCT05870150Not specifiedACTIVE_NOT_RECRUITINGChallenge Non-Typhoidal Salmonella (CHANTS) Study
NCT00002052Not specifiedCOMPLETEDProspective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients
NCT00177658Not specifiedCOMPLETEDNCCLS Interpretive Criteria for Salmonella
NCT02689193Not specifiedCOMPLETEDIDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres
NCT03073707Not specifiedCOMPLETEDReservoir of Invasive Salmonellosis in Children, DRC

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
SODIUM CHLORIDE42
AMPICILLIN SODIUM41
CEFTRIAXONE SODIUM41
NEISSERIA MENINGITIDIS POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID41
STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM19741
TYPHOID VI POLYSACCHARIDE VACCINE31
YELLOW FEVER VACCINE31
CHEMBL107803301
CHEMBL410139201